Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02101099 · ClinicalTrials.gov registry record

Effect of Anesthesia on Force Application During Colonoscopy

A clinical trial of Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases, sponsored by Artann Laboratories.

Completed
Registry status
102
Enrollment target
3
Study locations

NCT02101099: Completed study of Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases, sponsored by Artann Laboratories.

NCT02101099 is a study of Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases that has completed, run by Artann Laboratories. The registered enrollment target is 102 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02101099, a study of Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases, has completed, sponsored by Artann Laboratories.

COMPLETED
Registry status
102 participants
Enrollment target
3
Study locations

Study Summary

The aim of the study is to determine if more force is used during colonoscopy when patients receive monitored anesthesia with propofol versus conscious sedation. Force measurements will be performed using the colonoscopy force monitor (CFM). This device measures the magnitude and direction of force applied to the insertion tube of a standard colonoscope during colonoscopy.

Interventions

  • DEVICE Colonoscopy Force Monitor

Study Locations (3)

District of Columbia

  • Georgetown University Medical Center, Gastroenterology - Washington D.C.

Maryland

  • Chevy Chase Endoscopy Center - Chevy Chase

Pennsylvania

  • Univeristy of Pennsylvania Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2014-03
Est. Completion 2015-12
Artann Laboratories

14 total trials

What the finished NCT02101099 record still lists

NCT02101099 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Colonoscopy Force Monitor is the first listed.

NCT02101099 reports a single indexed study location in District of Columbia, Maryland, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02101099 about?

NCT02101099 is a clinical study titled "Effect of Anesthesia on Force Application During Colonoscopy". The aim of the study is to determine if more force is used during colonoscopy when patients receive monitored anesthesia with propofol versus conscious sedation. Force measurements will be performed using the colonoscopy force monitor (CFM). This device measures the magnitude and direction of force ...

What is the current status of trial NCT02101099?

This trial is currently completed. The enrollment target is 102 participants. The study started on 2014-03. Estimated completion is 2015-12.

What conditions does trial NCT02101099 study?

This clinical trial studies the following conditions: Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases.

What interventions are being tested in trial NCT02101099?

The interventions under investigation include: Colonoscopy Force Monitor (DEVICE).

Who is sponsoring clinical trial NCT02101099?

This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02101099 being conducted?

This trial has 3 study locations across District of Columbia, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02101099, the US trial registry maintained by the National Library of Medicine. NCT02101099 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.